Skip to content

VAPORIN, INC.: 10-Q/A filed 2012-09-13

What VAPORIN, INC. reported in its quarterly report amendment filed 2012-09-13 (fiscal Q2 2012): 17 published measures, 47 facts as tagged in accession 0001521536-12-000923.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2012-09-13
Fiscal period
fiscal Q2 2012
Accession
0001521536-12-000923 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VAPORIN, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-06-30888,963USD
At 2011-12-31905,072USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-06-30675,464USD
At 2011-12-3124,825USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-06-30213,499USD
At 2011-12-31880,247USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-06-30729,882USD
At 2011-12-31380,073USD
At 2011-06-301,647,562USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-4,565,897USD91
2012-01-01 to 2012-06-30-4,665,277USD182
2011-04-28 to 2012-06-30-5,785,060USD430
2011-04-28 to 2011-06-30-88,801USD64

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-1,992,789USD182
2011-04-28 to 2012-06-30-3,202,424USD430
2011-04-28 to 2011-06-30-142,406USD64

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-06-304,342,598USD182
2011-04-28 to 2012-06-305,932,306USD430
2011-04-28 to 2011-06-301,789,968USD64

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-2,000,000USD182
2011-04-28 to 2012-06-30-2,000,000USD430

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-06-3011,253USD182
2011-04-28 to 2012-06-3011,253USD430

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-4,563,363USD91
2012-01-01 to 2012-06-30-4,662,743USD182
2011-04-28 to 2012-06-30-5,782,526USD430
2011-04-28 to 2011-06-30-88,801USD64

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-06-30833,963USD
At 2011-12-31854,072USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-2,534USD91
2012-01-01 to 2012-06-30-2,534USD182
2011-04-28 to 2012-06-30-2,534USD430

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-04-01 to 2012-06-304,563,363USD91
2012-01-01 to 2012-06-304,662,743USD182
2011-04-28 to 2012-06-305,782,526USD430
2011-04-28 to 2011-06-3088,801USD64

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-06-3066,287,500shares
At 2011-12-3125,000,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-06-305,991,430USD
At 2011-12-311,997,530USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-04-01 to 2012-06-3048,043USD91
2012-01-01 to 2012-06-3057,395USD182
2011-04-28 to 2012-06-30109,035USD430
2011-04-28 to 2011-06-307,529USD64

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-2,534USD91
2012-01-01 to 2012-06-30-2,534USD182
2011-04-28 to 2012-06-30-2,534USD430

Inspect the source

Entity
VAPORIN, INC. / CIK 0001504937
Captured
SEC response SHA-256
f3f06619b9be1c0c43bf96455b6d9dd1e4218e9d1fcdd519d3dde1abea89948b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001504937.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))